{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:40:13Z","timestamp":1790516413923,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T00:00:00Z","timestamp":1268179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00520-010-0838-5","type":"journal-article","created":{"date-parts":[[2010,3,9]],"date-time":"2010-03-09T10:53:48Z","timestamp":1268132028000},"page":"467-473","source":"Crossref","is-referenced-by-count":23,"title":["Characteristics of patients with brain metastases from lung cancer in a palliative care center"],"prefix":"10.1007","volume":"19","author":[{"given":"Ryuya","family":"Yamanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatsuyo","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousuke","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsushi","family":"Fukushige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,10]]},"reference":[{"issue":"9","key":"838_CR1","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1200\/JCO.1992.10.9.1498","volume":"10","author":"CA Kristensen","year":"1992","unstructured":"Kristensen CA, Kristjansen PE, Hansen HH (1992) Systemic chemotherapy of brain metastases from small-cell lung cancer: a review. J Clin Oncol 10(9):1498\u20131502","journal-title":"J Clin Oncol"},{"key":"838_CR2","first-page":"2655","volume-title":"Cancer: principles and practice of oncology","author":"PY Wen","year":"1999","unstructured":"Wen PY, McLaren Black P, Loeffler JS (1999) Metastatic brain cancer. In: De Vita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 2655\u20132670","edition":"6"},{"key":"838_CR3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0360-3016(98)00442-8","volume":"43","author":"FJ Lagerwaard","year":"1999","unstructured":"Lagerwaard FJ, Levendag PC, Nowak PJCM et al (1999) Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 43:795\u2013803","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"838_CR4","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3171\/jns.2002.97.6.1276","volume":"97","author":"JP Sheenan","year":"2002","unstructured":"Sheenan JP, Sun MH, Kondziolka D et al (2002) Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control. J Neurosurg 97:1276\u20131281","journal-title":"J Neurosurg"},{"issue":"6","key":"838_CR5","first-page":"2474","volume":"42","author":"DJ Stewart","year":"1982","unstructured":"Stewart DJ, Leavens M, Maor M et al (1982) Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Res 42(6):2474\u20132479","journal-title":"Cancer Res"},{"issue":"8","key":"838_CR6","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199002223220802","volume":"322","author":"RA Patchell","year":"1990","unstructured":"Patchell RA, Tibbs PA, Walsh JW et al (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322(8):494\u2013500","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"838_CR7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000100659","volume":"61","author":"L Kihlstr\u00f6m","year":"1993","unstructured":"Kihlstr\u00f6m L, Karlsson B, Lindquist C (1993) Gamma Knife surgery for cerebral metastases. Implications for survival based on 16\u00a0years experience. Stereotact Funct Neurosurg 61(Suppl 1):45\u201350","journal-title":"Stereotact Funct Neurosurg"},{"issue":"2","key":"838_CR8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2214\/ajr.111.2.334","volume":"111","author":"J Horton","year":"1971","unstructured":"Horton J, Baxter DH, Olson KB (1971) The management of metastases to the brain by irradiation and corticosteroids. Am J Roentgenol Radium Ther Nucl Med 111(2):334\u2013336","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"issue":"Suppl 1","key":"838_CR9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000099810","volume":"66","author":"S Fukuoka","year":"1996","unstructured":"Fukuoka S, Seo Y, Takanashi M et al (1996) Radiosurgery of brain metastases with the Gamma Knife. Stereotact Funct Neurosurg 66(Suppl 1):193\u2013200","journal-title":"Stereotact Funct Neurosurg"},{"issue":"1","key":"838_CR10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0305-7372(90)90076-R","volume":"17","author":"HP Siegers","year":"1990","unstructured":"Siegers HP (1990) Chemotherapy for brain metastases: recent developments and clinical considerations. Cancer Treat Rev 17(1):63\u201376","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"838_CR11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/01.cco.0000183673.15133.e2","volume":"17","author":"S Taillibert","year":"2005","unstructured":"Taillibert S, Delattre JY (2005) Palliative care in patients with brain metastases. Curr Opin Oncol 17(6):588\u2013592","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"838_CR12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11060-008-9670-x","volume":"91","author":"A Pace","year":"2009","unstructured":"Pace A, Di Lorenzo C, Guariglia L et al (2009) End of life issues in brain tumor patients. J Neurooncol 91(1):39\u201343","journal-title":"J Neurooncol"},{"issue":"5","key":"838_CR13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1272\/jnms1923.38.267","volume":"38","author":"C Maruyama","year":"1971","unstructured":"Maruyama C (1971) Treatment of malignant tumors by an extract from tubercle bacilli (tuberculosis vaccine). Nippon Ika Daigaku Zasshi 38(5):267\u2013276","journal-title":"Nippon Ika Daigaku Zasshi"},{"key":"838_CR14","first-page":"2379","volume":"53","author":"V Rusch","year":"1993","unstructured":"Rusch V, Baselga J, Cordon-Cardo C et al (1993) Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res 53:2379\u20132385","journal-title":"Cancer Res"},{"key":"838_CR15","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/bjc.1998.106","volume":"77","author":"M Volm","year":"1998","unstructured":"Volm M, Rittgen W, Drings P (1998) Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas. Br J Cancer 77:663\u2013669","journal-title":"Br J Cancer"},{"key":"838_CR16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0163-7258(97)00052-1","volume":"77","author":"DS Lawrence","year":"1998","unstructured":"Lawrence DS, Niu J (1998) Protein kinase inhibitors: the tyrosine-specific protein kinases. Pharmacol Ther 77:81\u2013114","journal-title":"Pharmacol Ther"},{"issue":"1","key":"838_CR17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.lungcan.2004.05.014","volume":"47","author":"CH Chiu","year":"2005","unstructured":"Chiu CH, Tsai CM, Chen YM et al (2005) Gefitinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicity. Lung Cancer 47(1):129\u2013138","journal-title":"Lung Cancer"},{"issue":"3","key":"838_CR18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.lungcan.2007.03.011","volume":"57","author":"C Wu","year":"2007","unstructured":"Wu C, Li YL, Wang ZM et al (2007) Gefitinib as palliative therapy for lung adenocarcinoma metastatic to the brain. Lung Cancer 57(3):359\u2013364","journal-title":"Lung Cancer"},{"key":"838_CR19","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/annonc\/mdh276","volume":"15","author":"GL Ceresoli","year":"2004","unstructured":"Ceresoli GL, Cappuzzo F, Gregorc V et al (2004) Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial. Ann Oncol 15:1042\u20131047","journal-title":"Ann Oncol"},{"key":"838_CR20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2407-7-51","volume":"7","author":"H Yokouchi","year":"2007","unstructured":"Yokouchi H, Yamazaki K, Kinoshita I et al (2007) Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer. BMC Cancer 7:51","journal-title":"BMC Cancer"},{"issue":"3","key":"838_CR21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10147-005-0558-x","volume":"11","author":"M Sakai","year":"2006","unstructured":"Sakai M, Ishikawa S, Ito H et al (2006) Carcinomatous meningitis from non-small-cell lung cancer responding to gefitinib. Int J Clin Oncol 11(3):243\u2013245","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"838_CR22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.lungcan.2005.05.022","volume":"50","author":"MK Kim","year":"2005","unstructured":"Kim MK, Lee KH, Lee JK et al (2005) Gefitinib is also active for carcinomatous meningitis in NSCLC. Lung Cancer 50(2):265\u2013269","journal-title":"Lung Cancer"},{"issue":"1","key":"838_CR23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/thx.2005.052233","volume":"61","author":"CS Lai","year":"2006","unstructured":"Lai CS, Boshoff C, Falzon M, Lee SM (2006) Complete response to erlotinib treatment in brain metastases from recurrent NSCLC. Thorax 61(1):91","journal-title":"Thorax"},{"issue":"1","key":"838_CR24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.lungcan.2006.11.009","volume":"56","author":"S Popat","year":"2007","unstructured":"Popat S, Hughes S, Papadopoulos P et al (2007) Recurrent responses to non-small cell lung cancer brain metastases with erlotinib. Lung Cancer 56(1):135\u2013137","journal-title":"Lung Cancer"},{"issue":"3","key":"838_CR25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.lungcan.2007.05.018","volume":"58","author":"JW Chang","year":"2007","unstructured":"Chang JW, Chou CL, Huang SF et al (2007) Erlotinib response of EGFR-mutant gefitinib-resistant non-small-cell lung cancer. Lung Cancer 58(3):414\u2013417","journal-title":"Lung Cancer"},{"issue":"3","key":"838_CR26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.lungcan.2007.07.010","volume":"58","author":"V Gounant","year":"2007","unstructured":"Gounant V, Wislez M, Poulot V et al (2007) Subsequent brain metastasis responses to epidermal growth factor receptor tyrosine kinase inhibitors in a patient with non-small-cell lung cancer. Lung Cancer 58(3):425\u2013428","journal-title":"Lung Cancer"},{"issue":"31","key":"838_CR27","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1200\/JCO.2007.13.3751","volume":"25","author":"MH Fekrazad","year":"2007","unstructured":"Fekrazad MH, Ravindranathan M, Jones DV Jr (2007) Response of intracranial metastases to erlotinib therapy. J Clin Oncol 25(31):5024\u20135026","journal-title":"J Clin Oncol"},{"issue":"3","key":"838_CR28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000113928","volume":"31","author":"J Pawel von","year":"2008","unstructured":"von Pawel J, Wagner H, Duell T, Poellinger B (2008) Erlotinib in patients with previously irradiated, recurrent brain metastases from non-small cell lung cancer: two case reports. Onkologie 31(3):123\u2013126","journal-title":"Onkologie"},{"issue":"1","key":"838_CR29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11060-008-9623-4","volume":"90","author":"G Altavilla","year":"2008","unstructured":"Altavilla G, Arrigo C, Santarpia MC et al (2008) Erlotinib therapy in a patient with non-small-cell lung cancer and brain metastases. J Neurooncol 90(1):31\u201333","journal-title":"J Neurooncol"},{"issue":"2","key":"838_CR30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1183\/09031936.00162307","volume":"33","author":"AM Ruppert","year":"2009","unstructured":"Ruppert AM, Beau-Faller M, Neuville A et al (2009) EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up. Eur Respir J 33(2):436\u2013440","journal-title":"Eur Respir J"},{"key":"838_CR31","first-page":"309","volume":"5","author":"SD Baker","year":"1999","unstructured":"Baker SD, Wirth M, Statkevich P et al (1999) Absorption, metabolism and excretion of 14C-temozolomide following oral administration to patients with advanced cancer. Clin Cancer Res 5:309\u2013317","journal-title":"Clin Cancer Res"},{"key":"838_CR32","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1158\/1078-0432.CCR-03-0807","volume":"10","author":"S Ostermann","year":"2004","unstructured":"Ostermann S, Csajka C, Buclin T et al (2004) Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients. Clin Cancer Res 10:3728\u20133736","journal-title":"Clin Cancer Res"},{"issue":"2","key":"838_CR33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.lungcan.2005.05.026","volume":"50","author":"CG Giorgio","year":"2005","unstructured":"Giorgio CG, Giuffrida D, Pappalardo A et al (2005) Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: phase II study. Lung Cancer 50(2):247\u2013254","journal-title":"Lung Cancer"},{"issue":"2","key":"838_CR34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000192586","volume":"76","author":"C Kouroussis","year":"2009","unstructured":"Kouroussis C, Vamvakas L, Vardakis N et al (2009) Continuous administration of daily low-dose temozolomide in pretreated patients with advanced non-small cell lung cancer: a phase II study. Oncology 76(2):112\u2013117","journal-title":"Oncology"},{"key":"838_CR35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1012226718323","volume":"53","author":"LE Abrey","year":"2001","unstructured":"Abrey LE, Olson JD, Raizer JJ et al (2001) A phase II trial of TMZ for patients with recurrent or progressive brain metastases. J Neurooncol 53:259\u2013265","journal-title":"J Neurooncol"},{"key":"838_CR36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1023\/A:1008354323167","volume":"12","author":"C Christodoulou","year":"2001","unstructured":"Christodoulou C, Bafaloukos D, Kosmidis P et al (2001) Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases. Ann Oncol 12:249\u2013254","journal-title":"Ann Oncol"},{"issue":"1","key":"838_CR37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00520-002-0392-x","volume":"11","author":"E Davies","year":"2003","unstructured":"Davies E, Higginson IJ (2003) Communication, information and support for adults with malignant cerebral glioma: a systematic literature review. Support Care Cancer 11(1):21\u201329","journal-title":"Support Care Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-010-0838-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-010-0838-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-010-0838-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T17:39:20Z","timestamp":1591119560000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-010-0838-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,10]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["838"],"URL":"https:\/\/doi.org\/10.1007\/s00520-010-0838-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,10]]}}}